bioMérieux S.A. (FRA:EYWN)

Revenue by Product

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Clinical Applications	33.74B
Clinical Applications Growth	988.53%
Industrial Applications	606.00M
Industrial Applications Growth	5.34%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005
Americas	2.05B
Americas Growth	11.29%
EMEA	1.03B
EMEA Growth	6.63%
Asia Pacific	656.20M
Asia Pacific Growth	2.90%
France	240.10M
France Growth	6.47%
Corporate	600.00K
Corporate Growth	-33.33%